Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutic (NQ: HALO )

41.44 USD +0.01 (+0.02%)
Streaming Delayed Price Updated: 10:43 AM EDT, Sep 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,061
Open 41.56
Bid (Size) 41.40 (1)
Ask (Size) 41.45 (5)
Prev. Close 41.43
Today's Range 41.41 - 41.87
52wk Range 25.17 - 56.40
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will present at the 2021 Cantor Virtual Global Healthcare Conference on... 
From PR Newswire
Halozyme to Present at Wells Fargo 2021 Virtual Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present at the Wells Fargo 2021 Virtual Healthcare Conference on Friday,... 
From PR Newswire

Performance

YTD
-2.29%
-2.29%
1 Month
+1.82%
+1.82%
3 Month
-3.92%
-3.92%
6 Month
-0.17%
-0.17%
1 Year
+55.73%
+55.73%

More News

Read More
Halozyme Reports Second Quarter 2021 Results
From PR Newswire
Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference
From PR Newswire
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call
From PR Newswire
Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Aft
From PR Newswire
Halozyme Announces Janssen Receives European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation for Newly Diagnosed Systemic Light-chain Amyloidosis and Pre-Treated Multiple
From PR Newswire
Interesting HALO Put And Call Options For October 15th
Tags Stocks
From Market News Video
RSI Alert: Halozyme Therapeutics (HALO) Now Oversold
Tags Stocks
From Market News Video
Halozyme Therapeutics Moves Up In Market Cap Rank, Passing Perrigo
Tags Stocks
From Market News Video
Thinking about trading options or stock in Halozyme Therapeutics, GameStop, Digital Turbine, Tesla, or Moderna?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.